Replies to post #22208 on Mymetics Corp (MYMX)

[Work Harder]

FFUND

https://translate.google.com/translate?hl=en&sl=nl&u=https://ffund.nl/staff/carine-van-den-brink/&prev=search&pto=aue

REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research

https://translate.googleusercontent.com/translate_c?depth=1&hl=en&prev=search&pto=aue&rurl=translate.google.com&sl=nl&sp=nmt4&u=https://www.viroclinics.com/press-releases/reprocell-and-viroclinics-ddl-launch-new-collaboration-in-clinical-research/&usg=ALkJrhhr-UkiXtuGhzK3mvIwdl6TtIMWXg

M&A DEAL LIST 2019 PLACES AXON LAWYER CARINE VAN DE BRINK AT NO. 1

https://www.hollandbio.nl/nieuws/axon-advocaat-carine-van-de-brink-farma-kampioen/

[bow-tie]

U.S.-Licensed Influenza Vaccines, 2019-20
65 yrs older
Adjuvant IIV3 (egg) Fluad
High-dose IIV3 (egg) Fluzone High-dose
https://www2.cdc.gov/vaccines/ed/ciinc/archives/19/downloads/10_02/CIIW_10_02_19.pdf

hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method
Author links open overlay panelRobertusvan AalstabEllyn M.RussocNabinNeupanecSalaheddin M.Mahmudde JanWilschut fSandrine I.SamsongAymanChitbhMaartenPostmaaijYinongYoung-Xuck
Available online 20 June 2020.

https://www.sciencedirect.com/science/article/pii/S0264410X20307350?via%3Dihub

Vaccine effectiveness HD-IIV3High-dose influenza vaccine Instrumental variable IV adjustment Economic assessment Cardiovascular disease